扶正抗白冲剂对急性白血病患者长期存活影响的临床研究  

Clinical Study on Effect of Fuzheng Kangbai Granule on Long-Term Survival of Patients with Acute Leukemia

作　　者：麻柔[1] 刘锋[1] 杨经敏 马玲[1] 许勇钢[1] 胡乃平[1] 胡晓梅[1] 薛向军[1] 李柳[1] 王楠 

机构地区：[1]中国中医研究院西苑医院血液科,北京100091

出　　处：《中国中西医结合杂志》1998年第5期276-278,共3页Chinese Journal of Integrated Traditional and Western Medicine

基　　金：国家中医药管局重点课题资助!(No 92 2 15 3)

摘　　要：目的 :研究扶正抗白冲剂对急性白血病患者长期存活的影响 ,探讨扶正中药治疗微小残留白血病的机理。方法 :以扶正抗白冲剂治疗完全缓解期的急性白血病患者 90例 ,观察其对 5年持续缓解率 (EFI)和长期生存率 (OS)的影响 ;检测了用扶正抗白冲剂治疗前后患者免疫功能变化。结果 :90例患者 5年EFI为 64 2 % ,5年OS为 77 2 % ;患者免疫功能明显改善。结论 :扶正抗白冲剂可提高急性白血病患者 5年EFI和 5年长期生存率 ,这种提高可能是通过改善患者免疫功能达到的。Objective: To observe the effect of Fuzheng Kangbai Granule (FZKBG) on event free interval (EFI) and over survival (OS)of patients with acute leukemia, and to study the mechanism of FZKBG. Methods: FZKBG was used in 90 cases of completely remitted acute leukemia, immune functions of patients before and after using FZKBG were measured. Results: Five year EFI and OS were 64.2% and 77.2% of 90 cases of completely remitted acute leukemia, and the immune functions after using FZKBG have improved significantly. Conclusions: FZKBG could increase the EFI and OS of patients with acute leukemia, and the improved immune functions may play a role in increasing 5 year EFI and OS.

关 键 词：扶正抗白冲剂 急性白血病 生存质量 免疫功能 

分 类 号：R273.371[医药卫生—中西医结合]